Hepion Pharmaceuticals, Inc.
5 clinical trials · Sponsor
◉ Watch Hepion Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects (NCT05737433) | Hepion Pharmaceuticals, Inc. | 2023-03-01 |
| A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis (NCT05402371) | Hepion Pharmaceuticals, Inc. | 2022-10-15 |
| A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3 (NCT05461105) | Hepion Pharmaceuticals, Inc. | 2022-03-15 |
| A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects (NCT04480710) | Hepion Pharmaceuticals, Inc. | 2020-06-23 |
| A Study in Healthy Volunteers (NCT03596697) | Hepion Pharmaceuticals, Inc. | 2019-07-09 |
Track Hepion Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.